DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.
(30/05/2003)
Detail
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
(30/05/2003)
Detail
A case of voluminous diarrhoea with hypokalaemic acidosis.
(30/05/2003)
Detail
Inhibition of the cytochrome P-450 modulates all-trans-retinoic acid-induced differentiation and apoptosis of HL-60 cells.
(23/05/2003)
Detail
Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha.
(23/05/2003)
Detail
Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis.
(23/05/2003)
Detail
Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells.
(23/05/2003)
Detail
Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells.
(23/05/2003)
Detail
Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines.
(23/05/2003)
Detail
Protein kinase Calpha expression confers retinoic acid sensitivity on MDA-MB-231 human breast cancer cells.
(23/05/2003)
Detail
Activation of c-Jun amino-terminal kinase is required for retinoic acid-induced neural differentiation of P19 embryonal carcinoma cells.
(23/05/2003)
Detail
Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
(23/05/2003)
Detail
Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.
(23/05/2003)
Detail